XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Based Compensation Plan (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

A summary of stock option activity is set forth below (shares in thousands):

 

 

 

Options Outstanding

 

 

 

 

 

 

Weighted

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

Average

 

 

Remaining

 

 

Intrinsic

 

 

 

Number of

 

 

Exercise

 

 

Contractual Life

 

 

Value

 

 

 

Options

 

 

Price

 

 

(In years)

 

 

(In thousands)

 

Outstanding – December 31, 2022

 

 

3,896

 

 

$

2.43

 

 

 

8.44

 

 

 

 

Granted

 

 

1,603

 

 

 

0.89

 

 

 

 

 

 

 

Forfeited

 

 

(366

)

 

 

2.58

 

 

 

 

 

 

 

Expired

 

 

(1

)

 

 

1.87

 

 

 

 

 

 

 

Outstanding – March 31, 2023

 

 

5,132

 

 

 

1.94

 

 

 

8.32

 

 

$

11

 

Exercisable – March 31, 2023

 

 

1,728

 

 

 

1.95

 

 

 

6.49

 

 

 

2

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of options is estimated at the grant date using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 

 

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

 

2023

 

 

2022

 

Expected term (in years)

 

 

 

 

 

 

5.89

 

 

 

6.03

 

Expected volatility

 

 

 

 

 

 

85.82

%

 

 

80.15

%

Risk-free rate

 

 

 

 

 

 

3.93

%

 

 

1.59

%

Dividend yield

 

 

 

 

 

 

 

 

 

 

 

Summary of RSA Activity

The following table summarizes the Company’s restricted stock award activity (shares in thousands):

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

RSAs, unvested at December 31, 2022

 

 

105

 

 

$

9.74

 

Vested

 

 

(12

)

 

 

9.68

 

RSAs, unvested at March 31, 2023

 

 

93

 

 

 

9.75

 

Schedule of Stock-Based Compensation Expense

The total stock-based compensation expense recorded in the unaudited condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):

 

 

 

 

 

Three Months Ended March 31,

 

 

 

 

 

 

 

2023

 

 

2022

 

Research and development

 

 

 

 

 

$

343

 

 

$

333

 

General and administrative

 

 

 

 

 

 

786

 

 

 

583

 

Total stock-based compensation expense

 

 

 

 

 

$

1,129

 

 

$

916